Fallopian Tube Cancer - 25 Studies Found Status Study Completed Study Name: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Fallopian Tube Cancer Malignant Tumor of Peritoneum Date: 2007-02-15 Interventions: Drug: docetaxel 25 mg/m^2 give Not yet recruiting Study Name: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer Condition: Ovarian Epithelial Cancer Fallopian Tube Cancer Date: 2015-04-28 Interventions: Drug: p53 gene p53 gene will b Completed Study Name: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Biological: pegfilgrastim Drug: carboplati Completed Study Name: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Condition: Ovarian Cancer Primary Peritoneal Cancer Drug: PS-341 (Bortezomib) Star Withdrawn Study Name: Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin Condition: Fallopian Tube Cancer Ovarian Cancer Drug: carboplatin Drug: gemcitabine hydroc Terminated Study Name: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Ovarian Cancer Peritoneal Primary Cancer Other: healing touch The pract Completed Study Name: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Drug: AMG 386 Weekly Intraveno Completed Study Name: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Drug: RAD001 RAD001 10mg is ta <<< Previous | Next >>>